The goal of the trial is to evaluate the safety, tolerability and immunogenicity of the HIVconsvX vaccine -- a mosaic vaccine targeting a broad range of HIV-1 variants, making it potentially applicable for HIV strains in any geographical region.
Category: study
50% NextGen Indians shy away from talking sex in relationship: Survey
While generation Z and millennials clearly understand 'consent' as a prerequisite for engaging in sexual activity, both fear being judged for their thoughts when talking about sex in a serious relationship, according to a survey released on Monday.
94% of patients with cancer respond well to Covid vax: Study
Nearly 95 per cent of people with cancer developed a good immune response to the Covid-19 mRNA vaccines three to four weeks after receiving their second dose, finds a new study co-authored by Indian-origin researchers.
AstraZeneca says 92% vaccine effectiveness against Delta variant
AstraZeneca said new data from Public Health England (PHE) demonstrated COVID-19 Vaccine AstraZeneca, offers high levels of protection against the Delta variant (B.1.617.2; formerly the ‘Indian variant).
US researchers flag more deadly mutation in Gamma Covid variant
A mutation in the Gamma variant (P1) of coronavirus disease is linked to increased mortality, a Harvard T.H. Chan School of Public Health and MIT researchers said on Wednesday.
Oxford scientists to study ivermectin's efficacy for Covid treatment
A team of scientists at the University of Oxford have on Wednesday announced a trial to investigate the efficacy and safety of ivermectin -- an antiparasitic drug -- for people at more risk of serious illness from Covid-19.
Explained: How oxygen levels decline in Covid-19 patients
"Low blood-oxygen levels have been a significant problem in Covid-19 patients," said study lead Shokrollah Elahi, Associate Professor in the Faculty of Medicine and Dentistry at University of Alberta, Canada.
Vaccines give protection from severe illness against Covid variants: Study
Vaccines have been found to be effective in combating mutated variants and protect the vaccinated individual from severe illnesses, hospitalization, or death, reveals a study conducted by a Delhi-based Hospital.
Covid outcomes may be more severe in children: Study
Children with Covid-19 may not display typical symptoms such as fever, cough and shortness of breath, therefore more screening and vigilance are required, researchers warned.
3-layered cloth masks effective as surgical masks against Covid
For example, if an infected person and a healthy individual are both wearing masks, scientists believe this could result in up to 94 per cent less exposure, showed the findings published in the journal Physics of Fluids.
Effective vax against Covid mutations can be produced: AIIMS
In the first wave of coronavirus in India last year, virus mutations were not a major issue, but the ongoing second wave, where the spike in cases is much steeper, has led to variants concern, which are more infectious and lethal.
Study reveals cancer cells may evade chemotherapy
In the study, the researchers found that when AML cells were exposed to chemotherapy, a subset of the cells went into a state of hibernation, or senescence, while at the same time assuming a condition that looked very much like inflammation.
Heat treatment can make chemotherapy more effective: Study
'This therapy also has potential to reduce the side effects of chemotherapy, by ensuring it is more highly targeted on cancer cells rather than healthy tissue. These needs to be explored in further pre-clinical tests,' Thanh added.
Indian-origin engineers digitally communicates via human touch
The prototype, developed by Purdue University engineers, doesn't transfer money yet but it's the first technology that can send any information through the direct touch of a fingertip.
High BP in midlife is linked to increased brain damage: Study
Researchers have revealed that higher than normal blood pressure (BP) is linked to more extensive brain damage in the elderly, suggesting that it is important to control blood pressure long-term.
Most lungs recover well in 3 months after Covid: Study
The study from Radboud University in the Netherlands, published in the journal Clinical Infectious Diseases, included 124 patients who had recovered from acute Covid-19 infections.
MMR vaccine could protect against Covid-19: Study
In a fight against the novel Coronavirus, scientists have now claimed that MMR vaccine which protects against measles, mumps and rubella, may also protect some people against severe Covid-19 symptoms.
Covid antibodies detected up to 3 months after infection: Study
Researchers have revealed that the vast majority of individuals have detectable antibodies up to three months post contracting the SARS-CoV-2 virus, the virus that causes Covid-19.
Climate change will give rise to more cancers: Study
Researchers have revealed that climate change will extract an acute toll worldwide, with rising temperatures, wildfires and poor air quality, accompanied by higher rates of cancer, especially lung, skin and gastrointestinal cancers.
Nanoparticle vaccine candidate for Covid produces antibodies: Study
An innovative nanoparticle vaccine candidate for the Covid-19 virus produces virus-neutralizing antibodies in mice at levels 10X greater than is seen in people who have recovered from the infections, say researchers.
Covid virus may block formation of key red blood cells
In the study, published in the journal Archiv EuroMedica, researchers from Far Eastern Federal University (FEFU) in Russia, along with their Japanese colleagues probed how Covid-19's impact on red blood cells called erythrocytes affects patients.
Covid virus mutation may have made it more contagious: Study
The virus that causes Covid-19 is accumulating genetic mutations, one of which may have made it more contagious, says a study involving more than 5,000 patients in the US.
Risky sexual behaviour rising despite pandemic lockdowns: Study
The research, conducted in two main STI centres in Milan, Italy, found that despite the lockdown restrictions, diagnosis of STIs, including gonorrhoea, secondary syphilis and mycoplasma genitalium (MG) have increased.
Covid-19 antibodies provide lasting immunity: Study
For the findings, published in the journal 'Immunity', the research team lead by Indian-origin researcher in the US studied the production of antibodies from a sample of nearly 6,000 people to see the results.
Study supports airborne spread of Covid-19 in indoors
Researchers were able to link a community outbreak of Covid-19 in China to a source patient who likely spread the virus to fellow bus riders through the bus's air conditioning system.